FEMARA Side Effects

7014721-8 | Knee Arthroplasty
on Sep 16, 2010 Female patient from UNITED STATES , weighting 319.7 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: knee arthroplasty. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), STARLIX (20 Mg, Unk) (View Starlix Review and Starlix Label ), ACTOS (15 Mg, Unk) (View Actos Review and Actos Label ). Patient was hospitalized.

7014609-2 | Alopecia
Patient was taking Femara (View Usage). Patient had the following side effects: alopecia on Sep 24, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 160.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: Daily.

7013674-6 | Liver Disorder, Prostatitis, Surgery
Adverse event was reported on Jun 23, 2010 by a Male patient taking Femara (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?), prostatitis and. Location: JAPAN , 60 years of age, After Femara was administered, patient had the following side effects: liver disorder, prostatitis, surgery (What is surgery?). During the same period patient was treated with BACCIDAL (300 Mg, Unk) (View Baccidal Review and Baccidal Label ).

7009571-2 | Lung Disorder
on Sep 20, 2010 Female patient from INDIA , 58 years of age, was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: lung disorder. Femara dosage: 2.5 Mg, Qd.


7007294-7 | Visual Acuity Reduced
on Sep 14, 2010 Female patient from FRANCE , weighting 88.18 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient had the following side effects: visual acuity reduced. Femara dosage: 2.5 Mg/ Daily. During the same period patient was treated with CRESTOR (10 Mg/day) (View Crestor Review and Crestor Label ), PROTELOS (1 Df/day) (View Protelos Review and Protelos Label ), KARDEGIC (75 Mg/day) (View Kardegic Review and Kardegic Label ), ALDACTONE (75 Mg/day) (View Aldactone Review and Aldactone Label ).

7007035-3 | Blood Albumin Decreased, Blood Glucose Increased, Cough, Effusion, Glycosylated Haemoglobin Increased, Haematocrit Decreased, Haemoglobin Decreased, Hepatic Steatosis, Nasopharyngitis
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: blood albumin decreased, blood glucose increased, cough, effusion, glycosylated haemoglobin increased, haematocrit decreased, haemoglobin decreased, hepatic steatosis, nasopharyngitis on Sep 08, 2010 from JAPAN Additional patient health information: Female patient , weighting 108.0 lb, . Femara dosage: 2.5mg Daily. During the same period patient was treated with HERCEPTIN (Every 3 Weeks) (View Herceptin Review and Herceptin Label ). Patient was hospitalized.

7006612-3 | Inflammation Of Wound, Influenza Like Illness, Malignant Neoplasm Progression, Metastases To Breast, Metastases To Skin, Purulent Discharge, Scab
Adverse event was reported on Sep 13, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: GERMANY , 68 years of age, Patient experienced the following unwanted or unexpected effects: inflammation of wound, influenza like illness, malignant neoplasm progression, metastases to breast, metastases to skin, purulent discharge, scab (What is scab?).

7002593-7 | Arthralgia, Balance Disorder, Dizziness, Headache, Hypercholesterolaemia, Musculoskeletal Pain, Myalgia, Oophorectomy
on Sep 09, 2010 Female patient from GERMANY , 55 years of age, was diagnosed with breast cancer (What is breast cancer?), prophylaxis, pain (What is pain?) and was treated with Femara (View Usage). Patient had the following side effects: arthralgia, balance disorder, dizziness (What is dizziness?), headache (What is headache?), hypercholesterolaemia, musculoskeletal pain, myalgia, oophorectomy. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with METOPROLOL (Unk) (View Metoprolol Review and Metoprolol Label ), ZOMETA (Every Six Months) (View Zometa Review and Zometa Label ), IBUPROFEN (600, If Required) (View Ibuprofen Review and Ibuprofen Label ).

7000866-5 | Dysphagia, Gastrointestinal Tube Insertion
on Sep 07, 2010 Female patient from UNITED KINGDOM , 80 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: dysphagia, gastrointestinal tube insertion. Femara dosage: 2.5 Mg, Unk.

6985052-7 | Concomitant Disease Aggravated, Gait Disturbance, Wheelchair User
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: concomitant disease aggravated, gait disturbance, wheelchair user on Sep 06, 2010 from FINLAND Additional patient health information: Female patient , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: .

6985019-9 | Inflammation Of Wound, Influenza Like Illness, Metastases To Skin, Purulent Discharge, Scab
Adverse event was reported on Sep 03, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?) and. Location: GERMANY , 68 years of age, Patient had the following side effects: inflammation of wound, influenza like illness, metastases to skin, purulent discharge, scab (What is scab?).

6980516-4 | Amnesia, Hepatic Cirrhosis
on Sep 02, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with breast cancer (What is breast cancer?), deep vein thrombosis (What is deep vein thrombosis?), depression (What is depression?), constipation (What is constipation?), anxiety (What is anxiety?) and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: amnesia, hepatic cirrhosis. Femara dosage: 2.5 Mg, Daily. During the same period patient was treated with COUMADIN (7.5 To 10 Mg Depending) (View Coumadin Review and Coumadin Label ), PAXIL (20 Mg, Qd) (View Paxil Review and Paxil Label ), ENULOSE (30 Ml, Tid) (View Enulose Review and Enulose Label ), LORAZEPAM (1 Mg, Prn) (View Lorazepam Review and Lorazepam Label ).

6974326-1 | Blood Alkaline Phosphatase Increased, Blood Uric Acid Increased, Gamma-glutamyltransferase Increased, Gout
on Aug 30, 2010 Female patient from GERMANY , 66 years of age, was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood uric acid increased, gamma-glutamyltransferase increased, gout (What is gout?). Femara dosage: 2.5 Mg, 1 Daily.

6971882-4 | Arthralgia, Asthenia, Bone Pain, Crying, Fatigue, Hot Flush, Hyperhidrosis, Insomnia, Myalgia
Patient was taking Femara (View Usage). Patient had the following side effects: arthralgia, asthenia, bone pain, crying, fatigue, hot flush, hyperhidrosis, insomnia, myalgia on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 109.1 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: Once A Day.

6968548-3 | Feeling Abnormal
Adverse event was reported on Sep 06, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with breast cancer metastatic and. Location: UNITED KINGDOM , weighting 132.3 lb, After Femara was administered, patient had the following side effects: feeling abnormal. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg/day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), DIAZEPAM (2 Mg/day) (View Diazepam Review and Diazepam Label ), FOSAMAX (70 Mg) (View Fosamax Review and Fosamax Label ).

6968544-6 | Disease Progression
on Sep 03, 2010 Female patient from INDIA , 71 years of age, was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression. Femara dosage: 1 Df, Qd.

6968413-1 | Anaemia, Biopsy Bone Marrow Abnormal, Gastrointestinal Infection, Herpes Zoster, Hyperchlorhydria, Restless Legs Syndrome, Upper Respiratory Tract Infection, White Blood Cell Count Decreased
on Aug 24, 2010 Female patient from UNITED STATES , weighting 145.1 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Femara (View Usage). Patient had the following side effects: anaemia, biopsy bone marrow abnormal, gastrointestinal infection, herpes zoster, hyperchlorhydria, restless legs syndrome, upper respiratory tract infection, white blood cell count decreased. Femara dosage: Daily. During the same period patient was treated with CARTIA XT (Unk) (View Cartia Xt Review and Cartia Xt Label ), TRIAMTERENE AND HYDROCHLOROTHIAZID 75/50 (Unk) (View Triamterene And Hydrochlorothiazid 75/50 Review and Triamterene And Hydrochlorothiazid 75/50 Label ), TAMBOCOR (50 Mg, Bid) (View Tambocor Review and Tambocor Label ).

6966833-2 | Spleen Disorder
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: spleen disorder on Aug 24, 2010 from GERMANY Additional patient health information: Female patient , 76 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 2.5 Mg, Daily.

6966823-X | Arthralgia, Rheumatoid Arthritis
Adverse event was reported on Aug 24, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) . Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, rheumatoid arthritis (What is rheumatoid arthritis?).

6965224-8 | Feeling Of Body Temperature Change, Incontinence, Osteoporosis, Paraesthesia, Spinal Cord Herniation, Spinal Cord Operation
on Aug 23, 2010 Female patient from GERMANY , 72 years of age, was diagnosed with breast cancer (What is breast cancer?), hypothyroidism and was treated with Femara (View Usage). Patient had the following side effects: feeling of body temperature change, incontinence, osteoporosis (What is osteoporosis?), paraesthesia, spinal cord herniation, spinal cord operation. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with NOVOTHYRAL (View Novothyral Review and Novothyral Label ). Patient was hospitalized.

6958790-X | Asthenia, Colitis Ulcerative, Condition Aggravated, Diarrhoea, Irritability
on Aug 19, 2010 Female patient from UNITED STATES , weighting 133.4 lb, was diagnosed with breast cancer (What is breast cancer?), colitis ulcerative, vitamin d deficiency, hypertension and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: asthenia, colitis ulcerative, condition aggravated, diarrhoea, irritability. Femara dosage: 2.5 Mg Daily. During the same period patient was treated with PREDNISONE (2.5 Mg, Qd) (View Prednisone Review and Prednisone Label ), VITAMIN D (800 Mg, Qd) (View Vitamin D Review and Vitamin D Label ), LISINOPRIL (20 Mg, Qd) (View Lisinopril Review and Lisinopril Label ).

6956805-6 | Acute Coronary Syndrome, Alanine Aminotransferase Increased, Angina Pectoris, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Decreased, Blood Pressure Increased, Blood Thyroid Stimulating Hormone Increased, C-reactive Protein Increased, Cardiomegaly
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, alanine aminotransferase increased, angina pectoris, blood creatine phosphokinase increased, blood creatine phosphokinase mb decreased, blood pressure increased, blood thyroid stimulating hormone increased, c-reactive protein increased, cardiomegaly on Aug 25, 2010 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 207.2 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, sleep disorder (What is sleep disorder?), atrial fibrillation (What is atrial fibrillation?) and. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with MUNOBAL (5 Mg, Qd) (View Munobal Review and Munobal Label ), ZOPICLON (3.75 Mg, Qd) (View Zopiclon Review and Zopiclon Label ), BISOPROLOL FUMARATE (2.5 Mg, Bid) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AMIODARONE (100 Mg, Qd) (View Amiodarone Review and Amiodarone Label ), FALITHROM (Unk) (View Falithrom Review and Falithrom Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

6955292-1 | Depression, Emotional Disorder, Insomnia, Weight Increased
Adverse event was reported on Aug 18, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Daily) was diagnosed with breast cancer (What is breast cancer?), pain (What is pain?), insomnia and. Location: UNITED STATES , weighting 75.69 lb, Patient had the following side effects: depression (What is depression?), emotional disorder, insomnia, weight increased. During the same period patient was treated with POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), MOBIC (7.5 Mg, Qd) (View Mobic Review and Mobic Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), IBUPROFEN (400 Mg, Daily) (View Ibuprofen Review and Ibuprofen Label ), EXCEDRIN (MIGRAINE) (250 Mg, Prn) (View Excedrin (migraine) Review and Excedrin (migraine) Label ), EXCEDRIN P.M. (500 Mg, Qd) (View Excedrin P.m. Review and Excedrin P.m. Label ).

6942388-3 | Arrhythmia, Disease Progression, Dizziness, Fatigue, Feeling Abnormal, Heart Rate Increased, Hyperhidrosis
on Aug 13, 2010 Female patient from UNITED KINGDOM , 85 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), disease progression, dizziness (What is dizziness?), fatigue, feeling abnormal, heart rate increased, hyperhidrosis. Femara dosage: 2.5 Mg, Qd.

6938684-6 | Alopecia, Bronchitis, Depression, Headache, Hot Flush, Malaise, Nausea
on Aug 10, 2010 Female patient from SOUTH AFRICA , 63 years of age, was diagnosed with blood pressure abnormal and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, bronchitis (What is bronchitis?), depression (What is depression?), headache (What is headache?), hot flush, malaise, nausea (What is nausea?). Femara dosage: Unk. During the same period patient was treated with ELTROXIN (View Eltroxin Review and Eltroxin Label ). Patient was hospitalized.

6935853-6 | Acute Coronary Syndrome, Angina Pectoris, Blood Pressure Increased, Cardiomegaly, Dyspnoea At Rest, Ejection Fraction Decreased, Electrocardiogram Repolarisation Abnormality, Heart Rate Increased, Left Ventricular Failure
Patient was taking Femara (View Usage). Patient had the following side effects: acute coronary syndrome, angina pectoris, blood pressure increased, cardiomegaly, dyspnoea at rest, ejection fraction decreased, electrocardiogram repolarisation abnormality, heart rate increased, left ventricular failure on Aug 16, 2010 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 207.2 lb, was diagnosed with breast cancer (What is breast cancer?), hypertension, sleep disorder (What is sleep disorder?), atrial fibrillation (What is atrial fibrillation?) and. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with MUNOBAL (5 Mg, Qd) (View Munobal Review and Munobal Label ), ZOPICLON (3.75 Mg, Qd) (View Zopiclon Review and Zopiclon Label ), BISOPROLOL (2.5 Mg, Bid) (View Bisoprolol Review and Bisoprolol Label ), AMIODARONE (100 Mg, Qd) (View Amiodarone Review and Amiodarone Label ), FALITHROM (Unk) (View Falithrom Review and Falithrom Label ), RAMIPRIL (5 Mg, Qd) (View Ramipril Review and Ramipril Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

6935096-6 | Acute Hepatic Failure, Contusion, Disseminated Intravascular Coagulation, Hypoperfusion, Jaundice, Multi-organ Failure, Oedema
Adverse event was reported on Aug 12, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Unk) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 43 years of age, weighting 196.2 lb, After Femara was administered, patient had the following side effects: acute hepatic failure, contusion, disseminated intravascular coagulation, hypoperfusion, jaundice (What is jaundice?), multi-organ failure, oedema. During the same period patient was treated with ZOLADEX (3.6 Mg, Unk) (View Zoladex Review and Zoladex Label ), ANTIEMETICS (View Antiemetics Review and Antiemetics Label ), CYCLOPHOSPHAMIDE (1160 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (174 Mg, Unk) (View Epirubicin Review and Epirubicin Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ). Patient was hospitalized.

6934949-2 | Acute Hepatic Failure, Contusion, Disseminated Intravascular Coagulation, Hypoperfusion, Jaundice, Multi-organ Failure, Oedema
on Aug 12, 2010 Female patient from UNITED KINGDOM , 43 years of age, weighting 196.2 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, contusion, disseminated intravascular coagulation, hypoperfusion, jaundice (What is jaundice?), multi-organ failure, oedema. Femara dosage: 2.5 Mg, Unk. During the same period patient was treated with ZOLADEX (3.6 Mg, Unk) (View Zoladex Review and Zoladex Label ), ANTIEMETICS (View Antiemetics Review and Antiemetics Label ), CYCLOPHOSPHAMIDE (1160 Mg, Unk) (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (174 Mg, Unk) (View Epirubicin Review and Epirubicin Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ). Patient was hospitalized.

6934834-6 | Blood Pressure Increased, Conjunctivitis, Dry Skin, Fall, Headache, Hot Flush, Mucosal Dryness, Musculoskeletal Pain, Pelvic Pain
on Aug 06, 2010 Female patient from GERMANY , weighting 152.1 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient had the following side effects: blood pressure increased, conjunctivitis, dry skin, fall (What is fall?), headache (What is headache?), hot flush, mucosal dryness, musculoskeletal pain, pelvic pain (What is pelvic pain?). Femara dosage: 2.5 Mg Daily. During the same period patient was treated with CALCIUM VERLA (Unk) (View Calcium Verla Review and Calcium Verla Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), QUENSYL (Unk) (View Quensyl Review and Quensyl Label ).

6927649-6 | Anxiety, Arrhythmia, Arteriosclerosis Coronary Artery, Blood Pressure Increased, Chest Discomfort, Dizziness, Dyspnoea, Emphysema, Fatigue
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: anxiety (What is anxiety?), arrhythmia (What is arrhythmia?), arteriosclerosis coronary artery, blood pressure increased, chest discomfort, dizziness (What is dizziness?), dyspnoea, emphysema, fatigue on Aug 03, 2010 from GERMANY Additional patient health information: Female patient , weighting 119.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 2.5 Mg, Qd. During the same period patient was treated with BLOPRESS PLUS (1-0-1/2 Irregular Intake) (View Blopress Plus Review and Blopress Plus Label ), BAYOTENSIN (Unk) (View Bayotensin Review and Bayotensin Label ), METOPROLOL SUCCINATE (Bid) (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

6923814-2 | Confusional State, Nervous System Disorder
Adverse event was reported on Aug 06, 2010 by a Female patient taking Femara (View Usage) (Dosage: Unk) . Location: UNITED STATES , weighting 121.0 lb, Patient experienced the following unwanted or unexpected effects: confusional state, nervous system disorder.

6922944-9 | Alanine Aminotransferase Increased, Ascites, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Chromaturia, Decreased Appetite, Faeces Discoloured, Fatigue
on Aug 10, 2010 Female patient from FRANCE , weighting 348.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient had the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, blood lactate dehydrogenase increased, chromaturia, decreased appetite, faeces discoloured, fatigue. Femara dosage: 2.5 Mg, Qd.

6921545-6 | Malignant Neoplasm Progression, Mastectomy
on Aug 02, 2010 Female patient from MEXICO , 73 years of age, was diagnosed with breast cancer (What is breast cancer?), hypertension and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: malignant neoplasm progression, mastectomy (What is mastectomy?). Femara dosage: 1 Tablet (2.5 Mg) Per Day. During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), ARIMIDEX (View Arimidex Review and Arimidex Label ). Patient was hospitalized.

6915315-2 | Chest Pain, Fatigue, Increased Tendency To Bruise, Skin Atrophy
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), fatigue, increased tendency to bruise, skin atrophy on Aug 06, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with breast cancer stage iii and. Femara dosage: 2.5mg Daily Po.

6915121-9 | Activities Of Daily Living Impaired, Gait Disturbance, Malaise, Nausea, Pain In Extremity
Adverse event was reported on Aug 05, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg 1 X Day Buccal) was diagnosed with breast cancer recurrent, prophylaxis and. Location: UNITED STATES , 46 years of age, weighting 137.0 lb, Patient had the following side effects: activities of daily living impaired, gait disturbance, malaise, nausea (What is nausea?), pain in extremity.

6914044-9 | Foreign Body Sensation In Eyes, Retinal Haemorrhage, Retinal Vein Occlusion, Surgery, Vision Blurred, Visual Acuity Reduced
on Jul 28, 2010 Female patient from JAPAN , weighting 136.7 lb, was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: foreign body sensation in eyes, retinal haemorrhage, retinal vein occlusion, surgery (What is surgery?), vision blurred, visual acuity reduced. Femara dosage: 2.5 Mg Daily.

6914033-4 | Adenocarcinoma, Biopsy Bone, Bone Sarcoma, Fibrosis, Metastases To Bone
on Jul 29, 2010 Female patient from BRAZIL , weighting 119.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: adenocarcinoma, biopsy bone, bone sarcoma, fibrosis, metastases to bone. Femara dosage: 2.5 Mg, Daily. Patient was hospitalized.

6911258-9 | Rash, Skin Ulcer
Patient was taking Femara (View Usage). Patient had the following side effects: rash (What is rash?), skin ulcer on Jul 27, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, weighting 264.6 lb, was diagnosed with breast cancer metastatic and. Femara dosage: 2.5 Mg, Qd.

6911230-9 | Retinal Vascular Thrombosis, Vision Blurred, Visual Acuity Reduced
Adverse event was reported on Jul 26, 2010 by a Female patient taking Femara (View Usage) (Dosage: 1 Df Daily For 2 Years) was diagnosed with breast cancer (What is breast cancer?) and. Location: FRANCE , 80 years of age, After Femara was administered, patient had the following side effects: retinal vascular thrombosis, vision blurred, visual acuity reduced. Patient was hospitalized.

6906189-4 | Ovarian Cancer
on Jun 28, 2010 Female patient from UNITED KINGDOM , 80 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cancer. Femara dosage: .

6877019-4 | Anaemia, Asthenia, Pain, Vitamin B12 Deficiency, Vitamin D Decreased
on Jul 27, 2010 Female patient from UNITED STATES , 64 years of age, weighting 160.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). Patient had the following side effects: anaemia, asthenia, pain (What is pain?), vitamin b12 deficiency, vitamin d decreased. Femara dosage: 2.5mg 1 Tablet Daily Daily Po 3 More Years To Take.

6875919-2 | Joint Stiffness
Patient was taking Femara (View Usage). After Femara was administered, patient had the following side effects: joint stiffness on Jul 14, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 335.1 lb, was diagnosed with bone disorder and. Femara dosage: 2.5 Mg. During the same period patient was treated with CALCIUM W/COLECALCIFEROL (1 Df, Bid) (View Calcium W/colecalciferol Review and Calcium W/colecalciferol Label ), IBUPROFEN TABLETS (400 Mg, Tid, Prn) (View Ibuprofen Tablets Review and Ibuprofen Tablets Label ).

6839312-0 | Trigger Finger
Adverse event was reported on Jun 30, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg, Qd) was diagnosed with breast cancer (What is breast cancer?) and. Location: AUSTRALIA , 64 years of age, Patient experienced the following unwanted or unexpected effects: trigger finger. During the same period patient was treated with TAMOXIFEN (Unk) (View Tamoxifen Review and Tamoxifen Label ), ARIMIDEX (Unk) (View Arimidex Review and Arimidex Label ).

6839311-9 | Arthralgia, Ascites, Breast Prosthesis Implantation, Cataract, Fluid Retention, Medical Device Complication, Moaning, Oedema Peripheral, Weight Increased
on Jun 30, 2010 Female patient from AUSTRIA , 66 years of age, was diagnosed with breast cancer (What is breast cancer?), dehydration and was treated with Femara (View Usage). Patient had the following side effects: arthralgia, ascites, breast prosthesis implantation, cataract (What is cataract?), fluid retention, medical device complication, moaning, oedema peripheral, weight increased. Femara dosage: Unk. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), ZOMETA (Unk) (View Zometa Review and Zometa Label ), ARIMIDEX (Unk) (View Arimidex Review and Arimidex Label ).

6835814-1 | Impaired Work Ability, Mobility Decreased, Pain, Quality Of Life Decreased
on Jul 12, 2010 Female patient from UNITED STATES , 62 years of age, weighting 195.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: impaired work ability, mobility decreased, pain (What is pain?), quality of life decreased. Femara dosage: Daily.

6835466-0 | Lung Neoplasm Malignant, Lung Operation
Patient was taking Femara (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm malignant, lung operation on Jun 29, 2010 from BRAZIL Additional patient health information: Female patient , 68 years of age, weighting 132.3 lb, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 1 Tablet Daily. During the same period patient was treated with ERLOTINIB (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6822172-1 | Arthralgia, Back Pain, Joint Swelling, Weight Bearing Difficulty
Adverse event was reported on Jul 07, 2010 by a Female patient taking Femara (View Usage) (Dosage: 2.5 Mg Daily Po) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 66 years of age, weighting 155.0 lb, Patient had the following side effects: arthralgia, back pain (What is back pain?), joint swelling, weight bearing difficulty.

6816737-0 | Foreign Body Sensation In Eyes, Retinal Haemorrhage, Retinal Vein Occlusion, Surgery, Vision Blurred, Visual Acuity Reduced
on Jun 22, 2010 Female patient from JAPAN , weighting 136.7 lb, was treated with Femara (View Usage). After Femara was administered, patient had the following side effects: foreign body sensation in eyes, retinal haemorrhage, retinal vein occlusion, surgery (What is surgery?), vision blurred, visual acuity reduced. Femara dosage: 2.5 Mg Daily.

6816734-5 | Emotional Disorder, Insomnia, Weight Increased
on Jun 22, 2010 Female patient from UNITED STATES , weighting 75.69 lb, was diagnosed with breast cancer (What is breast cancer?), pain (What is pain?), insomnia and was treated with Femara (View Usage). Patient experienced the following unwanted or unexpected effects: emotional disorder, insomnia, weight increased. Femara dosage: 2.5 Mg, Daily. During the same period patient was treated with POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), MOBIC (7.5 Mg, Qd) (View Mobic Review and Mobic Label ), MULTI VITAMINS (Unk) (View Multi-vitamins Review and Multi-vitamins Label ), IBUPROFEN (400 Mg, Daily) (View Ibuprofen Review and Ibuprofen Label ), EXCEDRIN (MIGRAINE) (250 Mg, Prn) (View Excedrin (migraine) Review and Excedrin (migraine) Label ), EXCEDRIN P.M. (500 Mg, Qd) (View Excedrin P.m. Review and Excedrin P.m. Label ).

6816721-7 | Erythema, Lip Swelling
Patient was taking Femara (View Usage). Patient had the following side effects: erythema, lip swelling on Jun 22, 2010 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Femara dosage: 2.5 Mg, Qd.